Cargando…
Upregulation of the long non-coding RNA CBR3-AS1 predicts tumor prognosis and contributes to breast cancer progression
Breast cancer is the most common female malignancy and the major cause of cancer-related death in women. Long non-coding RNAs (lncRNAs), as oncogenic or tumor suppressor factor, involved in the development and progression of various cancers. In this study, we sought to investigate the function of ln...
Autores principales: | Xu, Lingyun, Zhu, Hong, Gao, Fei, Tang, Yinghua, Zhu, Yajun, Sun, Zhiqiang, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285981/ https://www.ncbi.nlm.nih.gov/pubmed/32550547 http://dx.doi.org/10.1016/j.gene.2019.100014 |
Ejemplares similares
-
Scars on the CBR?
por: Cohen, Andrew G, et al.
Publicado: (1997) -
Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker
por: Torkashvand, Safoora, et al.
Publicado: (2021) -
Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients
por: Morin-Buote, Jessica, et al.
Publicado: (2021) -
PGK1 inhibitor CBR-470-1 protects neuronal cells from MPP(+)
por: Zheng, Jinyu, et al.
Publicado: (2020) -
The CbrB Regulon: Promoter dissection reveals novel insights into the CbrAB expression network in Pseudomonas putida
por: Barroso, Rocío, et al.
Publicado: (2018)